The cardiovascular health of both men and women who wear tefillin (phylacteries) around their arms can improve, according to new research at the University of Cincinnati (UC). The study suggests those benefits are the result of ischemic, or reduced, blood-flow preconditioning that produces protection from the damage caused by heart attacks.
“Tefillin is used for morning prayers for Jewish men over the age of 13 on weekdays,” said clinical internal medicine Prof. Jack Rubinstein of the Division of Cardiovascular Health in UC’s College of Medicine.
“It is placed on the nondominant arm around the bicep and the forearm in a fairly tight manner,” he said. “It is never worn in a fashion as to occlude the blood flow. This is traditionally worn for about 30 minutes continuously during prayers, which involve sitting and standing, resulting in occasional retightening of the strap around your arm.”
The research was published in the peer-reviewed online journal PLOS ONE under the title “Tefillin use induces preconditioning associated changes in heart rate variability” and expands on similar research by Rubinstein from 2018 that enrolled only men in the study. This study included 14 men and 16 women.
The binding of the arm and the discomfort users often report may serve as a form of preconditioning and offer a substantial degree of protection against the damage that occurs when someone suffers a sudden loss of blood flow (acute ischemia) or after the blood supply is restored to a tissue or organ after an ischemic event (reperfusion), Rubinstein said. Such injuries occur during a heart attack when a section of the heart is deprived of oxygen and is then damaged further when blood flow is reestablished.
The researchers measured baseline information on all participants for 10 minutes in the morning, and then another round of data was obtained during and after 30 minutes of wearing the tefillin, he said. The 30 participants, all healthy individuals between the ages of 18 to 40, had their heart rate measured before, during and after the wearing of tefillin.
Wearing tefillin cased changes in heart rate
“What we found is that wearing tefillin in both males and females caused changes to the heart rate associated with lowering of the metabolism as measured via heart-rate variability,” Rubinstein said, adding that heart-rate variability is how much variability there is between one heartbeat and the next.
“We can measure all kinds of different things from heart-rate variability, including probably the most important, which is parasympathetic tone,” he said. “Does it relax you, and does it cause your metabolism to come down?”
The sympathetic and parasympathetic nervous systems have opposite roles. While the sympathetic nervous system carries signals that put the body’s systems on alert, the parasympathetic carries signals that relax those systems. The two systems work together to keep the body in balance. This study shows there is a measurable effect during and after wearing tefillin, Rubinstein said.
“It means that if we can have people wearing tefillin or a similar device, and they can get themselves to be preconditioned every day, we expect that those people should be protected or should have a decreased amount of damage if they should get a heart attack during the time they are protected,” he said. “This is a low-intensity way of protecting people from heart attacks.”
While wearing tefillin is a traditional practice of observant Jewish men, Rubinstein said this research did not include any usage of anything containing sacred religious texts.
According to the US Centers for Disease Control and Protection, heart attacks strike more than 800,000 people in the United States each year, he said, and that frequency makes this research potentially very impactful, he said.
“You have a very common and very deadly disease,” Rubinstein said. “We are showing a path through which anyone can precondition themselves to decrease the amount of damage that they suffer from a heart attack by wearing a very simple device. This is a potential game changer for how we approach cardiovascular disease prevention. Decreasing the amount of heart-attack damage by even just twofold is something that will change outcomes for millions of people.”